Clinical Stage Biotech

New York, United States & Waltham, Massachusetts – March 9, 2026 Dianthus Therapeutics, Inc., a clinical-stage biotechnology company focused...

LONDON, U.K., Feb. 23, 2026 — Hemogenyx Pharmaceuticals PLC announced the exercise of warrants and subsequent issue of new...

Lille & Paris, France — February 10, 2026: 4Moving Biotech (4MB), a clinical-stage biotechnology company and spin-off of 4P-Pharma,...

BOTHELL, Wash., Feb. 6, 2026 — Immunome, Inc., a clinical-stage biotechnology company developing targeted oncology therapeutics, announced that its...

SPRING HOUSE, Pa., Feb. 4, 2026 — Clinical-stage biotechnology company Third Arc Bio announced the closing of a $52...